Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
108: An all-star panel discuss EIS & VCTs in 2024 and look forward to 2025
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Update
Our research can be accessed for free under MIFID.
Find out more >
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Primary Health Properties
Property
Robust 1H results
By
Mike Foster
02 Aug 2018
Alliance Pharma Plc
Life Sciences
2018: a year of international progress
By
Dr Martin Hall
01 Aug 2018
Stay up-to-date with the latest research
Sign up to our newsletter
Avacta Group plc
Life Sciences
Ground-breaking new drug conjugate platform
By
Dr Martin Hall
30 Jul 2018
Arbuthnot Banking Group Plc
Financials
1H’18 results: continuing the good work
By
Mark Thomas
26 Jul 2018
Burford Capital
Financials
No need to appeal these results
By
Dr Brian Moretta
26 Jul 2018
The 600 Group
Industrial
Trading healthy, pension buyout, dividend restored
By
Paul Singer
25 Jul 2018
Morses Club Plc
Financials
Quality Street
By
Mark Thomas
19 Jul 2018
Scancell Holdings
Life Sciences
SCIB1 – Strong survival data
By
Dr Martin Hall
18 Jul 2018
City of London Investment Group
Financials
Dividend increase boosts yield
By
Dr Brian Moretta
17 Jul 2018
Burford Capital
Financials
Positive progress on Petersen
By
Dr Brian Moretta
13 Jul 2018
Evgen Pharma
Life Sciences
2018, a pivotal year
By
Dr Martin Hall
29 Jun 2018
Prev
1
...
18
19
20
21
22
...
30
Next
